MSI2 and hematopoietic and lymphoid system neoplasm: Musashi RNA-binding protein 2 (MSI-2) has been demonstrated to be involved in several solid and blood cancers, where its expression emerged to be higher than in normal tissues and correlate with the prognosis [17].